Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1591950

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1591950

Hyperpigmentation Disorders Treatment Market by Indication (Centrofacial Melasma, Malar Melasma, Mandibular Melasma), Treatment Type (Cosmeceuticals, Laser Therapy, Medication), End-User - Global Forecast 2025-2030

PUBLISHED:
PAGES: 187 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Hyperpigmentation Disorders Treatment Market was valued at USD 3.83 billion in 2023, expected to reach USD 4.03 billion in 2024, and is projected to grow at a CAGR of 5.73%, to USD 5.66 billion by 2030.

The market scope for Hyperpigmentation Disorders Treatment encompasses products and therapies designed to address conditions caused by excessive melanin production, resulting in skin discoloration issues such as melasma, age spots, and post-inflammatory hyperpigmentation. These treatments are critical for both dermatological health and cosmetic enhancement, providing options ranging from topical creams to advanced laser therapies. Applications span across dermatology clinics, cosmetic surgery centers, home-use products for self-care, and pharmaceuticals, targeting diverse end-users who seek these solutions for aesthetic and therapeutic benefits. Market growth is primarily driven by an increasing awareness of skin health, rising prevalence of hyperpigmentation among diverse demographics, and technological advancements in treatment methods. Furthermore, there is a growing consumer preference for cosmetic procedures and over-the-counter products that promise effective results with minimal side effects. However, challenges such as high costs of advanced treatments, regulatory hurdles, risks of adverse effects, and limited reimbursement policies can impede market expansion. Emerging opportunities lie in the development of innovative products like those with natural and organic ingredients, as well as minimally invasive procedures that leverage cutting-edge technologies while ensuring safety and efficacy. Companies are also encouraged to invest in education and promotion to raise awareness and decrease stigmas associated with hyperpigmentation. New markets in developing regions, where demand for dermatological solutions is rapidly climbing, offer significant growth prospects. Research should focus on personalized medicine approaches, integrating genomic technologies to tailor treatments to individual genetic profiles, and improving delivery mechanisms for higher efficacy. The market is competitive yet ripe with potential, characterized by constant innovation and a trend toward holistic and inclusive dermatological care solutions. By addressing these key areas, businesses can strategically position themselves for growth and leadership in the hyperpigmentation treatment market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.83 billion
Estimated Year [2024] USD 4.03 billion
Forecast Year [2030] USD 5.66 billion
CAGR (%) 5.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hyperpigmentation Disorders Treatment Market

The Hyperpigmentation Disorders Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of hyperpigmentation disorders
    • Rising awareness about importance of skincare among population
    • Increased expenditure on cosmetics and skincare products
  • Market Restraints
    • High cost of treatments and varying output results
  • Market Opportunities
    • Technological advancements like laser treatment and needling process
    • Surge in R&D activities to develop novel approaches for hyperpigmentation treatment
  • Market Challenges
    • Increasing skin sensitivity, allergies and reactions to some

Porter's Five Forces: A Strategic Tool for Navigating the Hyperpigmentation Disorders Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hyperpigmentation Disorders Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hyperpigmentation Disorders Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hyperpigmentation Disorders Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hyperpigmentation Disorders Treatment Market

A detailed market share analysis in the Hyperpigmentation Disorders Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hyperpigmentation Disorders Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hyperpigmentation Disorders Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hyperpigmentation Disorders Treatment Market

A strategic analysis of the Hyperpigmentation Disorders Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hyperpigmentation Disorders Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aerolase Corporation, Asclepion Laser Technologies GmbH, BIODERMA, Candela Corporation, Cosderma Cosmetology Institute, Cynosure LLC, Fade Out Ltd., Galderma S.A., iSCLINICAL, Lumenis Be Ltd., Lynton Lasers Ltd., Mesoestetics, Niche Beauty Lab, S.L., Obagi Cosmeceuticals LLC, PCA Skin by Colgate-Palmolive Company, Pureplay Skin Sciences (India) Private Limited, Skin Laundry Holdings LLC, Skincare by Dr V, and ZO Skin Health, Inc..

Market Segmentation & Coverage

This research report categorizes the Hyperpigmentation Disorders Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Centrofacial Melasma, Malar Melasma, and Mandibular Melasma.
  • Based on Treatment Type, market is studied across Cosmeceuticals, Laser Therapy, Medication, Microdermabrasion, and Phototherapy.
  • Based on End-User, market is studied across Dermatology Centers, Esthetic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-521BAA36EA82

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of hyperpigmentation disorders
      • 5.1.1.2. Rising awareness about importance of skincare among population
      • 5.1.1.3. Increased expenditure on cosmetics and skincare products
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatments and varying output results
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements like laser treatment and needling process
      • 5.1.3.2. Surge in R&D activities to develop novel approaches for hyperpigmentation treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing skin sensitivity, allergies and reactions to some
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hyperpigmentation Disorders Treatment Market, by Indication

  • 6.1. Introduction
  • 6.2. Centrofacial Melasma
  • 6.3. Malar Melasma
  • 6.4. Mandibular Melasma

7. Hyperpigmentation Disorders Treatment Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Cosmeceuticals
  • 7.3. Laser Therapy
  • 7.4. Medication
  • 7.5. Microdermabrasion
  • 7.6. Phototherapy

8. Hyperpigmentation Disorders Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Dermatology Centers
  • 8.3. Esthetic Centers
  • 8.4. Hospitals

9. Americas Hyperpigmentation Disorders Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hyperpigmentation Disorders Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hyperpigmentation Disorders Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aerolase Corporation
  • 3. Asclepion Laser Technologies GmbH
  • 4. BIODERMA
  • 5. Candela Corporation
  • 6. Cosderma Cosmetology Institute
  • 7. Cynosure LLC
  • 8. Fade Out Ltd.
  • 9. Galderma S.A.
  • 10. iSCLINICAL
  • 11. Lumenis Be Ltd.
  • 12. Lynton Lasers Ltd.
  • 13. Mesoestetics
  • 14. Niche Beauty Lab, S.L.
  • 15. Obagi Cosmeceuticals LLC
  • 16. PCA Skin by Colgate-Palmolive Company
  • 17. Pureplay Skin Sciences (India) Private Limited
  • 18. Skin Laundry Holdings LLC
  • 19. Skincare by Dr V
  • 20. ZO Skin Health, Inc.
Product Code: MRR-521BAA36EA82

LIST OF FIGURES

  • FIGURE 1. HYPERPIGMENTATION DISORDERS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HYPERPIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HYPERPIGMENTATION DISORDERS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CENTROFACIAL MELASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MALAR MELASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MANDIBULAR MELASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MICRODERMABRASION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY PHOTOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMATOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY ESTHETIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. HYPERPIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!